ENTITY

Myriad Genetics (MYGN US)

20
Analysis
Health CareUnited States
Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.
more
Company Presentation08 Nov 2024 05:30
Company Presentation09 Oct 2024 21:00
Company Presentation07 Aug 2024 04:30
Company Presentation08 Nov 2017 05:30
Company Presentation07 Feb 2018 05:30
x